Cue Biopharma, Inc. (CUE)
NASDAQ: CUE · IEX Real-Time Price · USD
0.670
-0.033 (-4.73%)
At close: Jul 26, 2024, 4:00 PM
0.686
+0.016 (2.39%)
After-hours: Jul 26, 2024, 7:11 PM EDT
Cue Biopharma Market Cap
Cue Biopharma has a market cap or net worth of $32.59 million as of July 26, 2024. Its market cap has decreased by -83.32% in one year.
Market Cap
32.59M
Enterprise Value
1.79M
1-Year Change
-83.32%
Ranking
Category
Stock Price
$0.67
Market Cap Chart
Since January 2, 2018, Cue Biopharma's market cap has decreased from $193.50M to $32.59M, a decrease of -83.16%. That is a compound annual growth rate of -23.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 34.20M | -71.28% |
| Dec 29, 2023 | 119.10M | 18.15% |
| Dec 30, 2022 | 100.80M | -71.94% |
| Dec 31, 2021 | 359.20M | -5.17% |
| Dec 31, 2020 | 378.80M | 3.78% |
| Dec 31, 2019 | 365.00M | 285.84% |
| Dec 31, 2018 | 94.60M | -51.11% |
| Jan 2, 2018 | 193.50M | - |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Xilio Therapeutics | 34.52M |
| iCAD, Inc. | 34.50M |
| Achilles Therapeutics | 34.48M |
| Immuneering | 34.10M |
| Exagen | 34.05M |
| NeuroBo Pharmaceuticals | 33.58M |
| ReWalk Robotics | 33.12M |
| CareCloud | 33.10M |